Facebook
X
LinkedIn
ForwardFundamentals of Anticancer Therapy Day 2 - Enduring Material - Credit offering period - March 19, 2026 - December 31, 2026
Review Take- Home Work
Mary E. Kern, MSN, RN, OCN, CHSE
*treatment/symptom management
Molecular Targeted Therapies and Immunotherapy
Jeremy Pappacena, PharmD, BCOP
Jennifer Niccolai, PharmD, BCOP
*treatment/symptom management
Hormone Therapy
Heather Kennihan MSN, RN, OCN
*treatment/symptom management
GI Toxicities and Assessment
Mary E. Kern, MSN, RN, OCN, CHSE
*treatment/symptom management
Treatment - BSA, ANC, Calvert, Mosteller
Mary E. Kern, MSN, RN, OCN, CHSE
*treatment
Additional Information
| Attachment | Size |
|---|---|
 AHNB21-208 (2-26) ACT Workbook Template_final.pdf | 3.62 MB |
| AHNB21-206 (2-26)_ACT book_final.pdf | 21.74 MB |
| AHNB21-207 (2-26) ACT SOP Manual 2026_final.pdf | 2.22 MB |
Accreditation: Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Allegheny General Hospital designates this enduring material activity for a maximum of 5.75 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Allegheny Health Network is approved as a provider for nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation
Available Credit
- 5.75 AMA PRA Category 1 Credit™
- 5.75 Attendance
- 5.75 NCPD
AHN West Penn Hospital is approved as a provider of nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses completing the entire activity and the evaluation tool will be awarded a maximum of 5.75 contact hours of nursing continuing professional development (NCPD).